[go: up one dir, main page]

ATE496029T1 - Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren - Google Patents

Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren

Info

Publication number
ATE496029T1
ATE496029T1 AT07785908T AT07785908T ATE496029T1 AT E496029 T1 ATE496029 T1 AT E496029T1 AT 07785908 T AT07785908 T AT 07785908T AT 07785908 T AT07785908 T AT 07785908T AT E496029 T1 ATE496029 T1 AT E496029T1
Authority
AT
Austria
Prior art keywords
pyridinylalkylene
alcohols
phenyl
derivatives
phosphodiesterase inhibitors
Prior art date
Application number
AT07785908T
Other languages
English (en)
Inventor
Gabriele Amari
Elisabetta Armani
Eleonora Ghidini
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE496029T1 publication Critical patent/ATE496029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT07785908T 2006-07-14 2007-07-06 Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren ATE496029T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06014672 2006-07-14
PCT/EP2007/005982 WO2008006509A1 (en) 2006-07-14 2007-07-06 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors

Publications (1)

Publication Number Publication Date
ATE496029T1 true ATE496029T1 (de) 2011-02-15

Family

ID=38691860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07785908T ATE496029T1 (de) 2006-07-14 2007-07-06 Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren

Country Status (10)

Country Link
US (1) US7671066B2 (de)
EP (1) EP2044023B1 (de)
CN (1) CN101490004B (de)
AR (1) AR062074A1 (de)
AT (1) ATE496029T1 (de)
DE (1) DE602007012105D1 (de)
HK (1) HK1135383A1 (de)
PE (1) PE20080552A1 (de)
TW (1) TW200813010A (de)
WO (1) WO2008006509A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022783A1 (de) * 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. 1-Phenyl-2-Pyridinylalkyl-Alkoholderivate als Phosphodiesterasehemmer
EP2070913A1 (de) * 2007-12-14 2009-06-17 CHIESI FARMACEUTICI S.p.A. Ester-Derivate als Phosphodiesterase-Hemmer
EP2110375A1 (de) 2008-04-14 2009-10-21 CHIESI FARMACEUTICI S.p.A. Phosphodiesterase-4-Hemmer der Tertiäraminklasse
EP2216327A1 (de) * 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. (1-Phenyl-2-Pyridin-4-yl)ethyl-benzoate als Phosphodiesterasehemmer
JP2013514970A (ja) 2009-12-21 2013-05-02 バイエル・クロップサイエンス・アーゲー チエニルピリ（ミ）ジニルアゾール及び植物病原性菌類を防除するためのそれらの使用
EP2560611B1 (de) 2010-04-21 2018-01-03 Chiesi Farmaceutici S.p.A. Verfahren zur bereitstellung von partikeln mit reduzierten elektrostatischen ladungen
CA2807406C (en) 2010-08-03 2018-12-11 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation comprising a phosphodiesterase inhibitor
CN102617457A (zh) * 2011-01-28 2012-08-01 天津药物研究院 一种制备罗氟司特的新方法
CN102060762B (zh) * 2011-01-28 2013-05-29 海南美大制药有限公司 孟鲁司特化合物及其新制法
CN103562185A (zh) 2011-06-06 2014-02-05 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇的衍生物
JP5759305B2 (ja) * 2011-08-19 2015-08-05 キヤノン株式会社 アクセス管理システム、アクセス管理方法、アクセス管理サーバ、連携サーバ、およびプログラム
EP2760838B1 (de) * 2011-09-26 2017-05-10 Chiesi Farmaceutici S.p.A. 1-phenyl-2-pyridinyl alkyl alcohol-derivaten als phosphodiesterase-inhibitoren
RU2617401C2 (ru) * 2011-10-21 2017-04-25 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстеразы
CN102603623A (zh) * 2011-12-26 2012-07-25 北京赛林泰医药技术有限公司 制备高纯度罗氟司特的方法
CN102417449A (zh) * 2012-01-09 2012-04-18 四川蜀中制药有限公司 一种3-环丙基甲氧基-4-二氟甲氧基苯甲酸的制备方法
WO2013131255A1 (en) 2012-03-07 2013-09-12 Scinopharm (Changshu) Pharmaceutical, Ltd. Preparation method of roflumilast
RU2637945C2 (ru) 2012-06-04 2017-12-08 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные 1-фенил-2-пиридинил-алкиловых спиртов в качестве ингибиторов фосфодиэстеразы
KR102192739B1 (ko) * 2012-12-05 2020-12-18 키에시 파르마슈티시 엣스. 피. 에이. 포스포디에스테라제 억제제로서 1-페닐-2-피리디닐 알킬 알코올의 유도체
RU2015121037A (ru) * 2012-12-05 2017-01-11 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные фенилэтилпиридина в качестве ингибиторов pde-4
US10366264B2 (en) * 2013-08-09 2019-07-30 Korea Advanced Institute Of Science And Technology System and method for transferring content among devices
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
CA2928242C (en) * 2013-10-22 2022-03-15 Chiesi Farmaceutici S.P.A. Process for the preparation of a pde4 inhibitor
CN103992220B (zh) * 2014-06-05 2015-11-18 山东省医学科学院药物研究所 一种罗氟司特中间体的制备方法
ES2702451T3 (es) * 2014-06-23 2019-03-01 Leo Pharma As Métodos para la preparación de compuestos heterocíclicos de 1,3-benzodioxol
CN104447244B (zh) * 2014-10-29 2017-06-06 成都森科制药有限公司 罗氟司特中间体及罗氟司特的制备方法
CN104447245B (zh) * 2014-10-29 2017-06-06 成都森科制药有限公司 罗氟司特中间体、中间体制备方法及罗氟司特的制备方法
CN105254559B (zh) * 2015-11-30 2017-07-11 山东罗欣药业集团股份有限公司 一种高纯度罗氟司特的制备方法
AU2016369371C1 (en) 2015-12-18 2021-05-13 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
US11220514B2 (en) 2017-06-20 2022-01-11 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2019129586A1 (en) 2017-12-28 2019-07-04 Chiesi Farmaceutici S.P.A. Use of 1-phenyl-2-pyridinyl alkyl alcohol derivatives for treating cystic fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652868B1 (de) * 1992-07-28 2004-11-10 Aventis Pharma Limited Inhibitoren von c-amp phosphodiesterase
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation

Also Published As

Publication number Publication date
CN101490004B (zh) 2012-01-11
HK1135383A1 (en) 2010-06-04
EP2044023B1 (de) 2011-01-19
TW200813010A (en) 2008-03-16
DE602007012105D1 (de) 2011-03-03
US20080015226A1 (en) 2008-01-17
PE20080552A1 (es) 2008-06-24
WO2008006509A1 (en) 2008-01-17
US7671066B2 (en) 2010-03-02
EP2044023A1 (de) 2009-04-08
AR062074A1 (es) 2008-10-15
CN101490004A (zh) 2009-07-22

Similar Documents

Publication Publication Date Title
ATE496029T1 (de) Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
DE602005025733D1 (de) Pyrazolopyrimidinderivate als inhibitoren der cyclinabhängigen kinase
ATE543816T1 (de) Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase
SMT201600267B (it) Inibitori di syk imidazopirazinici
ATE478064T1 (de) Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate
ATE520671T1 (de) Pyrimidin-harnstoff-derivate als kinase-hemmer
EP2170076A4 (de) 4-carboxybenzylamino-derivate als histondeacetylase-hemmer
CR10369A (es) Pyrimidine derivatives as pi3k inhibitors
ATE506358T1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
BRPI0915231A2 (pt) compostos inibidores de quinase e métodos de uso
DE602007008837D1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
DE602006008945D1 (de) Isochinolinderivate als inhibitoren von rho-kinase
ATE512972T1 (de) Pyrrolopyrazole als wirksame kinaseinhibitoren
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
ATE524467T1 (de) Neuartige aza-heterozyklen als kinase-inhibitoren
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
EP2300013A4 (de) Phosphor-derivate als kinase-inhibitoren
ATE537147T1 (de) Azabiphenylaminobenzoesäurederivate als dhodh- inhibitoren
DK2848610T3 (da) Hæmmere af kinaseaktivitet
EP2192838A4 (de) Heterocyclische nekroptose-hemmer
ATE510825T1 (de) Acylaminopyrazole als fgfr-inhibitoren
ATE540936T1 (de) Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer
NO345061B1 (no) Anvendelse av DPP-IV inhibitorer
ATE549340T1 (de) Spiroindolinon-derivate als mdm2-p53 inhibitoren
SMT201200061B (it) Composti di pirazina come inibitori della fosfodiesterasi 10

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties